These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26051997)

  • 1. An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathways.
    Wala SJ; Karamchandani JR; Saleeb R; Evans A; Ding Q; Ibrahim R; Jewett M; Pasic M; Finelli A; Pace K; Lianidou E; Yousef GM
    Mol Oncol; 2015 Oct; 9(8):1667-77. PubMed ID: 26051997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of gene expression and integrin-associated signaling pathways in papillary renal cell carcinoma subtypes.
    Zhang K; Lee HM; Wei GH; Manninen A
    Oncotarget; 2016 Dec; 7(51):84178-84189. PubMed ID: 27705936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dismantling papillary renal cell carcinoma classification: The heterogeneity of genetic profiles suggests several independent diseases.
    Marsaud A; Dadone B; Ambrosetti D; Baudoin C; Chamorey E; Rouleau E; Lefol C; Roussel JF; Fabas T; Cristofari G; Carpentier X; Michiels JF; Amiel J; Pedeutour F
    Genes Chromosomes Cancer; 2015 Jun; 54(6):369-82. PubMed ID: 25820192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
    Huang J; Dong B; Zhang J; Kong W; Chen Y; Xue W; Liu D; Huang Y
    Tumour Biol; 2014 Jun; 35(6):5833-43. PubMed ID: 24609899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
    Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
    Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.
    Butz H; Szabó PM; Khella HW; Nofech-Mozes R; Patocs A; Yousef GM
    Oncotarget; 2015 May; 6(14):12543-57. PubMed ID: 26002553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-199a-3p acts as a tumor suppressor in clear cell renal cell carcinoma.
    Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
    Pathol Res Pract; 2018 Jun; 214(6):806-813. PubMed ID: 29773428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer.
    Xiong Y; Zhang L; Holloway AK; Wu X; Su L; Kebebew E
    PLoS One; 2011; 6(10):e24717. PubMed ID: 21998631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA profiles classify papillary renal cell carcinoma subtypes.
    Wach S; Nolte E; Theil A; Stöhr C; T Rau T; Hartmann A; Ekici A; Keck B; Taubert H; Wullich B
    Br J Cancer; 2013 Aug; 109(3):714-22. PubMed ID: 23799849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Analysis of Three Publicly Available Gene Expression Profiles Identified Genes and Pathways Associated with Clear Cell Renal Cell Carcinoma.
    Han Y; Wang L; Wang Y
    Med Sci Monit; 2020 Jul; 26():e919965. PubMed ID: 32712616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.